Viktimne insider-transakcje ble offentliggjort onsdag, som fremhever en kombinasjon av strategiske kjøp og obligatoriske salg blant flere amerikanske børsnoterte selskaper.
Zentalis Pharmaceuticals Inc. (ZNTL) reported a director-level purchase of 4.34 million shares on August 14, 2026, at $3.50 per share for a total of $15.17 million. Walters Group, a 10% owner and director entity, increased its beneficial ownership to 17.84 million shares. الأسهم انخفضت بنسبة 11% خلال الأسبوع الماضي لكنها ما زالت ترتفع بنسبة 140% على أساس سنوي.
Bakkt Inc. (BKKT) saw a director purchase 296,567 Class A shares on August 18, 2026, at a weighted-average price of $7.12, totaling $2.11 million. The transaction occurred as the stock traded near its 52-week low of $6.75, down 33% over the past six months.
Universal Safety Products Inc. documented purchases by director Milton C. Ault III between August 17 and 19, 2026, totaling $201,392. Transaktiók közé tartozott közvetlen és nem közvetlen vásárlás, a részvény ára 3,83 dollár és 5,87 dollár között mozgott.
Advanced Flower Capital Inc. (AFCG) reported a purchase by a director of 12,841 shares on August 19, 2026, at prices between $3.48 and $3.50 for a total of $44,686. السهم ارتفع بنسبة 27% خلال الأسبوع الماضي و65% خلال ستة أشهر.
Brilliant Earth Group Inc. (BRLT) раскрыла, что генеральный директор Бет Тамара Герстин приобрела 10 000 акций класса A в период с 18 по 19 августа 2026 года за 12 532 доллара по ценам от 1,25 до 1,26 доллара за акцию. Акция находится вблизи своего 52-ухнедельного минимума в 1,00 доллара и упала на 36% за последний год.
Na sell stránce, spoločnosť Astera Labs Inc. (ALAB) oznámila povinné predaje od prezidenta a výkonného riaditeľa Sanjaya Gajendry a výkonného riaditeľa Jitendra Mohana 17. augusta 2026, aby pokryli daňové povinnosti za odmeňované obmedzené akcie. Každý z nich predal 86 180 akcií za ceny od 333,60 USD do 352,11 USD, čo predstavuje celkovo približne 30,8 milióna USD na riaditeľa. Akcie sa v súčasnosti obchodujú za 289,80 USD, čo je pokles o takmer 118% za šesť mesiacov.
Adaptive Biotechnologies Corp (ADPT) revealed that CEO Chad M. Robins sold approximately $14.88 million worth of shares between August 17 and 18, 2026, following the exercise of stock options. The sales took place at prices between $24.48 and $25.57 per share, with the stock near its 52-week high of $26.16 after a 107% gain over the past year.
PACS Group Inc. (PACS) reported that CEO Jason Hulse Murray sold 236,116 stocks between August 17 and 19, 2026, under a prearranged trading plan adopted in May 2026. The sales totalled $10.44 million at prices between $43.34 and $44.85 per share.
